The Dose Dependent Effects of Ruxolitinib on the Invasion and Tumorigenesis in Gliomas Cells via Inhibition of Interferon Gamma-Depended JAK/STAT Signaling Pathway
A STAT3-based gene signature stratifies glioma patients for targeted therapy | Nature Communications
Can immunotherapy tackle glioblastoma?
Tumor-associated reactive astrocytes aid the evolution of immunosuppressive environment in glioblastoma | Nature Communications
Inhibition of the Invasion of Human Glioblastoma U87 Cell Line by Ruxolitinib: A Molecular Player of miR-17 and miR-20a Regu
The Dose Dependent Effects of Ruxolitinib on the Invasion and Tumorigenesis in Gliomas Cells via Inhibition of Interferon Gamma-Depended JAK/STAT Signaling Pathway
Frontiers | Targeting tumor-associated macrophages for the immunotherapy of glioblastoma: Navigating the clinical and translational landscape
Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapy - ScienceDirect
Lineage and Spatial Mapping of Glioblastoma-associated Immunity | bioRxiv
Cancers | Free Full-Text | Untwining Anti-Tumor and Immunosuppressive Effects of JAK Inhibitors—A Strategy for Hematological Malignancies? | HTML
Ruxolitinib enhanced the anti-tumor activity of chemotherapy agents in... | Download Scientific Diagram
Ruxolitinib Plus Radiation and Temozolomide for Newly Diagnosed Grade III Gliomas and Glioblastoma | PracticeUpdate
Transient prenatal ruxolitinib treatment suppresses astrogenesis during development and improves learning and memory in adult mice | Scientific Reports
TROY signals through JAK1-STAT3 to promote glioblastoma cell migration and resistance - ScienceDirect
Tumor-associated reactive astrocytes aid the evolution of immunosuppressive environment in glioblastoma | Nature Communications
Combination of VSV-GP and ruxolitinib enhances virus replication in the... | Download High-Quality Scientific Diagram
JCI - Immunostimulatory bacterial antigen–armed oncolytic measles virotherapy significantly increases the potency of anti-PD1 checkpoint therapy
Transient prenatal ruxolitinib treatment suppresses astrogenesis during development and improves learning and memory in adult mice | Scientific Reports
Survival is improved for VSV-IFNβ with the addition of ruxolitinib in a... | Download Scientific Diagram
TROY signals through JAK1-STAT3 to promote glioblastoma cell migration and resistance - ScienceDirect
